Viking Therapeutics
VKTX
VKTX
143 hedge funds and large institutions have $212M invested in Viking Therapeutics in 2020 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 44 increasing their positions, 50 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
8% less capital invested
Capital invested by funds: $230M → $212M (-$17.6M)
12% less repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 50
Holders
143
Holding in Top 10
–
Calls
$4.78M
Puts
$2.87M
Top Buyers
| 1 | +$3.41M | |
| 2 | +$2.92M | |
| 3 | +$2.15M | |
| 4 |
Two Sigma Investments
New York
|
+$1.27M |
| 5 |
Group One Trading
Chicago,
Illinois
|
+$1.06M |
Top Sellers
| 1 | -$3.08M | |
| 2 | -$2.03M | |
| 3 | -$1.45M | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$1.42M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$1.08M |